CVB homepage

Trending
'Not sustainable': The real impact of RVU cuts in electrophysiology
Family files $17M lawsuit after young girl’s heart valve allegedly implanted upside down
CMS proposes major TAVR changes, including Medicare coverage for asymptomatic patients
Medline recalls nearly 50K procedure kits, including many used by cardiologists
Looking ahead to the future of FFR-CT
older patient with a doctor at their house
AFib patients with gout face greater stroke risk—but therapy can help

Gout often goes undertreated, but targeting these patients with urate-lowering therapy can make a big impact on their long-term cardiovascular health.

Cardiawave announced the first routine clinical use in Europe of its Valvosoft system since its CE mark regulator clearance in late 2025. It is a noninvasive, high-intensity ultrasound therapy to fragment leaflet calcium in severe symptomatic aortic stenosis, and I is aimed at patients who are not ideal for surgical or transcatheter aortic valve replacement, or who decline surgical intervention.
High-intensity ultrasound technology for calcified valve leaflets makes debut in Europe

The new technology was designed for patients who may not be able to undergo SAVR or TAVR.

Cardiologist Michael McMullan explains his surprise about high levels of soft coronary plaque seen on CCTA despite years of intensive statin therapy. #YesCCT
CCTA scan at conference gives cardiologist a wake-up call

Cardiologist Michael McMullan, MD, was surprised by his own CCTA results, highlighting the substantial impact these scans can make on patient care. 

Example of a left atrial posterior wall (LAPW) pulmonary vein isolation (PVI) to better treat persistent atrial fibrillation (AFib) using the Abbott electromapping system.
Targeting the left atrial posterior wall during pulsed field ablation fails to improve outcomes

Researchers explored the potential of an alternate way to perform PFA on patients with persistent AFib, presenting their findings live at AF Symposium 2024 in Boston.

FDA approved the first transcatheter tricuspid valve (TTVR) replacement device in February 2024, the EVOQUE system from Edwards Lifesciences. The Evoque is the first transcatheter tricuspid valve approved by the FDA. The Evoke the first transcatheter tricuspid cleared in the United States.
Edwards makes history, receives FDA approval for transcatheter tricuspid valve replacement device

The approval, based on positive results from the TRISCEND II trial, represents a significant milestone for the treatment of severe tricuspid regurgitation. 

Medtronic's PulseSelect Pulsed Field Ablation (PFA) System
Real-world patients now being treated with Medtronic’s PFA system

Medtronic is celebrating the success of its PulseSelect pulsed field ablation product by highlighting its impact on heart patients around the world. 

man in prison behind bars
Cardiologist’s alleged sexual assaults prompt lawmakers to introduce new legislation

While Stephen Matthews sits in jail for allegedly raping women he met online, lawmakers are saying his case is evidence that dating apps need to be better regulated.

Patient
CT-first strategy the most effective path forward when evaluating stable chest pain

Heart teams have several options when patients present with stable chest pain and require further testing. According to a brand new analysis of nearly 800 patients, CCTA may be the best place to start. 

Tablet projecting metaphorical medical hologram
AI-powered risk score predicts how heart failure patients will respond to loop diuretics

New research out of Texas could go a long way toward improving care for patients with acute decompensated heart failure.

Innovation at work

Cardiovascular Business
Fewer biopsies, happier patients: Why molecular blood testing is a game-changer for managing heart transplant recipients

Follow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms.  

In cooperation with CareDx

Around the web

Health Exec
Major grocery operator on the hook for $40M over pharmacy monkey business; $6M windfall for whistleblower
Health Exec
Hospitals serving Medicaid patients prepare to take proposed payment caps on the chin
Radiology Business
Boston researchers land $9M grant to advance molecular neuroimaging